After BioNTech SE reported that its COVID-19 vaccine candidate BNT162b2 was over 90% efficient in a Phase III...
Up To Date
Latest News
Evotec SE is set to expand the company's existing campus in Milton Park/Abingdon, UK, into a major,...
Pfizer and Biontech SE have reached an agreement with the European Commission to supply 200 million doses of...
More than 1,800 attendees already registered for the Global Bioeconomy Summit 2020. The conference takes place...
Interim data on BioNtech’s/Pfizer’s COVID-19 vaccine candidate BNT162b2 suggest an efficacy of more than 90% -...
Swiss drugmaker Vifor Pharma has licenced US and EU commercialisation rights of Angion Biomedica’s...